Keyword

RC48

Description: A HER2-targeting antibody-drug conjugate, also known as disitamab vedotin, investigated as a cancer treatment.
OpenAlex ID: keywords/rc48
2019 · Gabriel Rinnerthaler, Simon Peter Gampenrieder, et al. · International Journal of Molecular Sciences · 243
2022 · Fan Shi, Yanli Liu, et al. · Drug Delivery · 236
2024 · Hui-Hui Hu, Sai-Qi Wang, et al. · International Journal of Oncology · 32
2024 · Weisong Li, Kai Zhang, et al. · Journal of Experimental & Clinical Cancer Research · 29
2025 · Jiatong Xiao, Jinhui Liu, et al. · Journal for ImmunoTherapy of Cancer · 18
2024 · Jinchao Chen, Mingchao Wang, et al. · Clinical Genitourinary Cancer · 15
Works count: 123
Citation count: 1,714
Year
Topic
Type